{"meta":{"query_hash":"9a7c9df4db3d","filters":{"venue":"Indonesian Journal of Biomedicine and Clinical Sciences"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9a7c9df4db3d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Indonesian+Journal+of+Biomedicine+and+Clinical+Sciences"},"results":[{"id":"W4415371933","doi":"10.22146/inajbcs.v57i3.supplement.24251","title":"Effectiveness and safety of camrelizumab combined with pemetrexed-carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC): a systematic review and meta-analysis","year":2025,"lang":"","type":"review","venue":"Indonesian Journal of Biomedicine and Clinical Sciences","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Pemetrexed; Adverse effect; Jadad scale; Hazard ratio; Chemotherapy; Survival rate; Immunotherapy","score_opus":0.027789815321777635,"score_gpt":0.4037758252972134,"score_spread":0.37598600997543574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415371933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005357521,0.9930775,0.00034502082,0.00013802038,0.000105096326,0.0003241851,0.0003926083,0.000019740728,0.0002403732],"genre_scores_gemma":[0.16667275,0.8271092,0.0020040316,0.0010536935,0.00022605402,0.0015103405,0.0008766809,0.00003423715,0.0005129628],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99393207,0.0026544349,0.0019408152,0.00061126635,0.00066476216,0.00019669195],"domain_scores_gemma":[0.9919292,0.005445388,0.0014732655,0.00026095592,0.0007342508,0.00015705802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009465989,0.0024617936,0.01923192,0.005131109,0.0005568924,0.003006755,0.0020696032,0.0022042675,0.0029984072],"category_scores_gemma":[0.018676419,0.0013186993,0.03466793,0.0058148387,0.0006636543,0.0017462706,0.0013127446,0.0015312174,0.00032404542],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016870253,0.00003579775,0.0017218837,0.5066558,0.47919506,0.000106981446,0.000090962116,0.0004631873,0.00025254523,0.00011559788,0.00041216027,0.009262929],"study_design_scores_gemma":[0.0005319408,0.00022965118,0.002091759,0.0273973,0.96781844,0.000081169586,0.00004339266,0.000161804,0.0001042247,0.00012831503,0.0013886088,0.000023389171],"about_ca_topic_score_codex":0.0056875246,"about_ca_topic_score_gemma":0.013843213,"teacher_disagreement_score":0.01923192,"about_ca_system_score_codex":0.0025453314,"about_ca_system_score_gemma":0.0033337006,"threshold_uncertainty_score":0.050061524},"labels":[],"label_agreement":null}]}